NEWHALL CHARLES W III sold 1.0% of their position (1.41K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $63.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/26/2025ACC: 0001005544-25-000004
Director
Since Feb 2026
-1.41K
Net shares
Net seller
$63.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.41K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.41K
Price / share
$45.00
Trade value
$63.54K
% of position
1.0%
8/22/2025
135.64K→134.23K
Total
Net shares
−1.41K
Net value
-$63.54K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/22/2025 | S · Sale | −1.41K | $45.00 | $63.54K | 1.0% | 135.64K | 134.23K |
| Total | −1.41K | -$63.54K | ||||||
Derivative Transactions0
No derivative transactions reported